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Background: Hypoxia inducible factor-1α (HIF-1α) is the central transcriptional regulator of hypoxic responses during
the progression of pituitary adenomas. Although previous immunohistochemical studies revealed that HIF-1α is
expressed in adreno-cortico-tropic-hormone (ACTH) pituitary adenomas, the role of HIF-1α remains unclear.
Methods: AtT-20 cells were incubated under hypoxic conditions (1 % O2) for 12 h. HIF-1α mRNA and protein
expression levels were measured by real-time PCR and western blotting, respectively. BrdU was used to determine the
effects of hypoxia on cell viability. AtT-20 cells were transfected with siRNA targeting HIF-1α, followed by hypoxia (1 %
O2) for 12 h. Apoptosis was determined by annexin V-FITC flow cytometry and Tdt-mediated dUTP nick end-labelling
(TUNEL) assay. In addition, we examined interactions between HIF-1α, glucocorticoid receptor (GR), and dexamethasone
under both normoxic and hypoxic conditions.
Results: Hypoxia triggered the time-dependent proliferation of AtT-20 cells in association with increased HIF-1α
mRNA and protein levels. However, the viability of AtT-20 cells decreased greatly when they were first transfected
with HIF-1α-siRNA and then exposed to hypoxia. According to flow cytometry (annexin V-FITC and PI staining)
and TUNEL analyses, a greater percentage of cells were apoptotic when transfected with HIF-1α siRNA and subsequently
cultured under hypoxic conditions compared to those in the normoxia and mock groups. After AtT-20 cells were
cultured in 1 % O2 and then treated with dexamethasone, HIF-1α levels significantly increased or decreased in
normoxic or hypoxic conditions, respectively. Dexamethasone suppressed GR expression to a higher degree in
hypoxic than normoxic conditions. Downregulation of GR by dexamethasone was greatly prevented in cells that
were transfected with HIF-1α siRNA.
Conclusions: These findings strongly suggest that HIF-1α exerts an antiapoptotic role and participates in the
downregulation of GR by dexamethasone in hypoxic AtT-20 cells.
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Pituitary adenomas are less vascularised [1] and oxygen-
ated [2] compared to the anterior and posterior lobes of
the pituitary gland, in contrast to other malignant neo-
plasms. This phenomenon suggests that pituitary adenoma
cells might acquire tolerance to hypoxia. Normally,
hypoxia can induce tumour cell death [3]; however, the
presence of necrotic or apoptotic changes is rarely
observed in pituitary adenomas [4].
Hypoxia inducible factor-1α (HIF-1α) is the central
transcriptional regulator of the hypoxic response. Acti-
vated HIF-1α drives the transcription of more than 2 %
of all human genes either directly or indirectly to adjust
the homeostasis of cells under hypoxic conditions [5]. A
previous article reported that HIF-1α is expressed in
ACTH pituitary adenomas [6]. However, the roles of
HIF-1α in the development and clinical presentation of
ACTH pituitary adenomas remain unknown.
The relationship between HIF-1α and apoptosis was re-
cently revealed [7]. It remains controversial whether hypoxia
induces a pro- or antiapoptotic process [8]. Coincidently,
adaptation to hypoxic environments is also influenced
by glucocorticoids. There is cross-talk between hypoxia-
dependent signals and glucocorticoid-mediated regulation of
gene expression [9-11]. However, the cross-talk between
HIF-1α and glucocorticoid pathways remains poorly defined.
In the present study, we employed a special hypoxia incu-
bator [12,13] and HIF-1α siRNA to study the effects of
HIF-1α expression on the proliferation and protection from
apoptosis in AtT-20 cells in vitro. We also explored the
interactions of HIF-1α, glucocorticoid receptor (GR), and
dexamethasone under both normoxic and hypoxic
conditions.
Methods
Cell culture and hypoxia induction
AtT-20 cells were obtained from the American Type
Culture Collection (Manassas, VA, USA) and routinely
cultured in Ham’s-F12K medium (Gibco, USA), supple-
mented with 2 mM L-glutamine, 1.5 g/L sodium bicar-
bonate (82.5 %), horse serum, (15 %), and foetal bovine
serum (Gibco, BRL) (2.5 %) at 37 °C in a humidified at-
mosphere containing 5 % carbon dioxide. For hypoxic ex-
posure, cells were cultured in a specifically designed
hypoxia incubator (Thermo Electron, Forma, MA) in an
atmosphere consisting of 94 % N2, 5 % CO2, and 1 % O2.
Reagents
Dexamethasone and dimethyl sulfoxide (DMSO) were
purchased from Sigma-Aldrich. The short-interfering
RNA (siRNA) against mouse HIF-1α and mock siRNA
(nonsense sequence) were purchased from Santa Cruz
Technology (Santa Cruz, CA). All other reagents were of
the highest analytical grade available.BrdU
Cell proliferation of AtT-20 cells in hypoxic conditions
was measured by a BrdU incorporation assay. Cells
under different treatments were plated onto 96-well
plates. These cells were subjected to BrdU using the
BrdU Cell Proliferation Kit (Cell Signaling, USA) follow-
ing the manufacturer’s instructions. Three independent
experiments were performed. Next, we employed Multi-
sizer 3 COULTER COUNTER to count the AtT20 cell
numbers. Before counting the sample, flush the system
and count PBS as a blank control. Put 0.2 ml of suspen-
sion of cells into 10 ml PBS, and then mix the sample
thoroughly. Turn the glass valve directly above the cells
to vertical, and then turn it back to horizontal to begin
the count. The count displayed is the the number of
cells in 0.5 ml.RNA extraction and real-time PCR
RNA was prepared using the TRIzol reagent (Invitrogen,
Carlsbad, CA, USA). One microgram of total RNA, 1 μL
oligo(dT) 15 primer (Promega, USA) and DEPC water
were added to a total volume of 10 μL, heated to 70 °C
for 5 min, and placed on ice for 5 min. Then a mixture
of M-MLV RT 5× reaction buffer (5 μL), 100 mM
dNTPs (0.5 μL), 1 μL M-MLV RT H(−) point mutant,
and DEPC water in a final volume of 15 μL (all from
Promega, Madison, USA) was added to each sample,
followed by incubation at 40 °C for 60 min and 70 °C for
15 min. Real-time PCR was performed using the SYBR®
Premix Ex Taq™ PCR kit (Takara, Japan) on the Applied
Biosystems 7300 Real-Time PCR System (Foster, CA,
USA). The 20-μL reaction of the SYBR Green assay con-
tained 10 μL of 2× SYBR Premix Ex Taq, 0.4 μL PCR
forward primers and 0.4 μL reverse primers, 0.4 μL ROX
reference dye (50×), 2 μL cDNA, and 6.8 μL double-
distilled H2O. PCR was carried out as follows: one cycle
of 95 °C for 10 s (pre-denature) and 40 cycles of two
steps (95 °C for 5 s and 60 °C for 31 s). At the end of
the amplification, a dissociation curve (melting curve)
was plotted in the temperature range 65–95 °C. All
amplifications and detections were carried out in a
MicroAmp optical 96-well reaction plate with optical ad-
hesive covers (Applied Biosystems). PCRs were per-
formed in triplicate, and a reliable internal control under
hypoxia, 28S rRNA, was co-amplified to normalize the
amount of RNA added to the reaction [14]. Normoxia
group in Fig. 1b, 1 % O2-0 h without dexamethasone in
Fig. 3a and 3b, 1 % O2-0 h in Fig. 4a and 4b were used
as calibrator for relative quantitative PCR. All data were
analysed using the Applied Biosystems 7300 SDS Soft-
ware (Applied Biosystems, CA, USA). -2-△△ct method
was used to analyze the real time PCR results.
Primer sequences were as follows:
Fig. 1 Effects of hypoxia on proliferation of AtT-20 cells. (a) AtT-20 cells were incubated under hypoxic (1% O2) and normoxia conditions for the
indicated times (0, 3, 6, and 12 h). Brdu assay showed hypoxia incubation stimulated the proliferation of AtT-20 cells in a time-dependent manner
compared with normoxia group (*P < 0.05 vs. normoxia groups). Cells transfected with HIF-1α-siRNA then cultured in hypoxic incubator for 12 h
diminished the BrdU incorporation (#P < 0.05 vs. mock). Knock-down of AtT-20 cells with HIF-1α siRNA (10 μM) was evaluated by real-time PCR (b) and
western blot (c) (P < 0.05 vs. mock). The hypoxic and normoxia incubation time is 12 h. (d) Quantification of (c). Independent experiments were
repeated at least three times and similar results were obtained




28S rRNA: forward: 5’- AATGCCTCGTCATCTAAT-3’
reverse 5’- TTCGCTGGATAGTAGGTA-3’.
We designed the 28S rRNA primers online. The web-
site was sigma.com/probedesignonline. Actually, we had
searched many literatures about the 28S primers of
mouse, but it was difficult to find a matched one.
Western blot analysis
Cells were extracted by centrifugation at 3000 rpm for
2 min, followed by one cold PBS wash and lysed in lysisbuffer (RIPA 1:1, PMSF 100:1, and protein inhibitor 1:200).
After a 30-min incubation on ice, cell lysates were centri-
fuged at 13000 rpm at 4 °C for 15 min. Total proteins were
quantified by the Thermo Scientific Pierce BCA protein
assay kit according to its instruction. One hundred micro-
grams of sample were first electrophoresed on a 7.5 %
SDS-polyacrylamide gel and transferred to PVDF mem-
branes. Ponceau S staining was performed on the mem-
branes to ensure successful transfer. After transfer, the
membranes were blocked with 10 % fat-free milk for 2 h at
room temperature, and then incubated with either rabbit
polyclonal anti-HIF-1α antibody (H-206, Santa Cruz) at a
1:500 dilution at 4 °C overnight or anti-GR antibody
(M-20, Santa Cruz, CA, USA) at a 1:500 dilution for 2 h at
room temperature. After washing three times with 1 ×
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with anti-rabbit IgG, HRP-linked secondary antibody (HIF-
1α, 1:20,000 or GR, 1:3000) and visualized using a chemi-
luminescence detection kit, ECL-PLUS (Amersham Bio-
sciences). Anti-β-actin (mouse monoclonal, 1:20,000;
Calbiochem, La Jolla, CA) was used as protein control. The
relative amount of protein was quantified by densitometry
using Image J software.
Knock-down of HIF-1α protein expression with siRNA
AtT-20 cells (4 × 105) were seeded into 12-well plates
without antibiotics and incubated at 37 °C for 5 h to 90 %
confluence. Four microlitres of 10 μM HIF-1α siRNA
(Santa Cruz, CA, USA) and 2 μL Lipofectamine 2000
(Invitrogen, Carlsbad, CA, US) were gently mixed with
100 μL siRNA transfection medium (OPTI-MEM, Gibco,
BRL, USA) for 5 min at room temperature, and the
mixtures were then combined and incubated at room
temperature for another 20 min to form siRNA-
Lipofectamine 2000 complexes. The complexes were fi-
nally added to the cells. After incubation at 37 °C for 24 h,
cells were cultured with medium containing antibiotics
and cultured in 1 % O2 for 12 h. The efficiency of the HIF-
1α knock-down by siRNA was evaluated by real-time PCR
and western blot. Mock siRNA (Santa Cruz, CA) was
transfected as a negative control.
Annexin V-FITC detecting system
Apoptotic cells were detected using the annexin V-FITC
apoptosis detection kit (BD Biosciences Pharmingen).
Cells were seeded into 24-well plates at a density of
40 × 104 cells per well. After a 12-h incubation in hyp-
oxic conditions and transfection with HIF-1α-siRNA,
cells were washed twice with cold PBS and then resus-
pended in 200 μL 1 × binding buffer. One hundred
microlitres of the above cell solution were transferred
into a 5-mL tube, and 5 μL of annexin V-FITC and 5 μL
of PI were added. The tubes were gently vortexed and
incubated for 15 min at room temperature in the dark.
Four hundred microlitres of 1× binding buffer was
added, and the cells were analysed by flow cytometry
(BD FACS Calibur) within 1 h. For each measurement
10 000 cells were analyzed.
Tunel staining
FACS data on apoptosis was further verified using the ter-
minal deoxynucleotidyl transferase (Tdt)-mediated dUTP
nick end-labelling (TUNEL) assay. The TUNEL technique
was performed using the in situ cell death detection kit
(Roche Diagnostics, Indianapolis, IN, USA), according to
the manufacturer’s instructions. Chamber slides were fixed
with 4 % paraformaldehyde for 1 h, and 0.1 % Triton-100
in 0.1 % sodium citrate was added at 4 °C for 2 min. The
slides were incubated with the TUNEL reactionmixture for 1 h at 37 °C. After washing, the slides were
further incubated with alkaline phosphatase-conjugated
anti-fluorescein antibody for 30 min at 37 °C. Slides were
developed using Fast Red (DAKO, Carpenteria, CA, USA)
and lightly counterstained with hematoxylin.TUNEL posi-
tive cells were observed under confocal microscopy.
TUNEL-positive cells per field were counted in 5 random
fields under 40× magnifications, and positive cell percent-
ages were averaged.
Statistical analysis
The two tailed Student’s t test was used to analyse the
data. Results are expressed as means ± SEM. P less than
0.05 was considered statistically significant.
Results
Hypoxia triggered the proliferation of AtT-20 cells
through the induction of HIF-1α mRNA and protein
expression
AtT-20 cells were incubated under hypoxic (1 % O2) and
normoxia conditions for the indicated time points (0, 3,
6, or 12 h). As shown in Fig. 1a, the BrdU assay showed
that hypoxia stimulated the proliferation of AtT-20 cells
in a time-dependent manner compared with that of the
normoxic group (P < 0.05) without any signs of cytotox-
icity. Under hypoxic conditions (1 % O2) for 12 h, cells
transfected with mock siRNA did not show significantly
reduced BrdU incorporation compared with untrans-
fected cells. In contrast, cells transfected with HIF-1α-
specific siRNA showed significantly diminished BrdU in-
corporation (Fig. 1a). AtT20 cell numbers (using a
Coulter counter) were consistent with the BrdU results
(data not shown). These findings were associated with
the expression of HIF-1α mRNA and protein, as detected
by real-time PCR (Fig. 1b) and western blotting (Fig. 1c
and d), respectively.
Role of HIF-1α in protecting AtT-20 cells from
hypoxia-induced apoptosis
To further determine possible mechanisms through which
HIF-1α contributes to AtT-20 cell growth and prolifera-
tion, RNA interference for HIF-1α was employed by trans-
fecting cells with a specific siRNA against mouse HIF-1α
mRNA. After transfecting HIF-1α siRNA, an annexin V-
FITC apoptosis detection system was employed to deter-
mine whether HIF-1α might shield AtT-20 cells from
hypoxia-induced apoptosis. Multiple siRNA concentra-
tions were tested; transfection of 10 μM HIF-1α siRNA for
48 h knocked down hypoxia-induced HIF-1α mRNA and
protein expression levels by more than 50 %. The relative
mRNA expression levels of HIF-1α according to real-
time PCR were 1.00 under normoxic conditions and
2.867 ± 0.3946 in 1 % O2 (P < 0.05). Relative expression
of HIF-1α was significantly reduced to 1.180 ± 0.0694
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not show significant changes in the relative expression
of HIF-1α in 1 % oxygen (Fig. 1b). Western blots also
showed higher expression of HIF-1α under hypoxic condi-
tions and reduced expression by siRNA (Fig. 1c and d).
These experiments indicate a firm gene-silencing effect
on HIF -1α by siRNA at the mRNA and protein levels.
Annexin V-FITC detection by flow cytometry showed
increased early apoptosis when cells were transfectedFig. 2 Role of HIF-1α in protecting AtT-20 cells from hypoxia-induced apopto
transfected, and subsequently cultured in hypoxic or normoxic conditions for
apoptosis when cells were transfected with HIF-1α siRNA and subsequently c
groups (*P < 0.05 vs.the other groups)with HIF-1α siRNA and subsequently cultured in 1 %
O2 for 12 h (28.90 % and 10.00 %, P < 0.05) (Fig. 2a)
compared with the normoxia and mock groups. These
results were confirmed by TUNEL assay. We found that
TUNEL-positive cells were weakly expressed in the nor-
moxia and mock groups. However, a significantly
greater proportion of cells transfected with siRNA tar-
geting HIF-1α mRNA and cultured in 1 % O2 were
TUNEL positive (Fig. 2b).sis. AtT-20 cells were transfected with 10 μM HIF-1α siRNA or mock
12h. (a) Annexin V-FITC and (b) TUNEL assay showed increased
ultured in 1% O2 for 12 h compared with normoxia and mock
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HIF-1α in GR downregulation after administration of
dexamethasone in hypoxic conditions
Next, we tested HIF-1α and GR changes in AtT-20 cells
after hypoxic incubation (0, 6, 12, and 24 h) and dexa-
methasone treatment (24 h). Briefly, AtT-20 cells pre-
treated with dexamethasone (10 nM or 100 nM) for 1 h
were first incubated under hypoxic conditions (1 % O2)
for the indicated time and then under normoxic condi-
tions for the remaining time. Under normoxic condi-
tions, dexamethasone (10 nM and 100 nM) increased
mRNA and protein expression levels of HIF-1α, but had
the opposite effect after hypoxic incubation (Fig. 3a, c
and d). Dexamethasone suppressed HIF-1α expression
in a hypoxia-dependent manner. Downregulation of GR
mRNA and protein by dexamethasone was more obvious
under hypoxic conditions than under normoxic condi-
tions (Fig. 3b-d).
AtT-20 cells were transfected with HIF-1α-siRNA and
then cultured in normoxia or hypoxic incubator for 12 hFig. 3 Interaction of HIF-1α, GR, and glucocorticoids after administration of de
(10 nM or 100 nM, 24h) on HIF-1α (a, c) and GR (b, c) mRNA and protein expr
at 0 h. #P < 0.05 vs. 100 nM at 0 h. (d) Quantification of (c) (*,# P < 0.05 vs. hypto further clarify whether downregulation of GR by
dexamethasone treatment (24h) under hypoxic condi-
tions was HIF-1α dependent. As shown in Fig. 4b-d,
mRNA and protein expression levels of GR were in-
creased in cells transfected with HIF-1α siRNA and
grown under hypoxic conditions compared to those of
nontransfected cells after administration of dexametha-
sone (P < 0.05). In contrast, the mock transfection group
exhibited no obvious changes in GR expression levels.
Discussion
In the current study, we found that hypoxic incubation
(1 % O2) triggered the growth and proliferation of AtT-
20 cells through the induction of HIF-1α expression at
the mRNA and protein levels. Transfection of HIF-1α
siRNA resulted in the death of most cells. Furthermore,
we performed an annexin V-FITC assay to detect early
apoptosis and a TUNEL assay to determine the antiapop-
totic role of HIF-1α in AtT-20 cells. A greater percentage
of cells transfected with HIF-1α siRNA underwentxamethasone under hypoxic conditions. Effects of dexamethasone
ession levels under normoxic and hypoxic conditions. *P < 0.05 vs. 10nM
oxia 24 h)
Fig. 4 Downregulation of GR by dexamethasone under hypoxia conditions was HIF-1α-dependent. Under normoxia or hypoxic incubation for
12h, mRNA and protein expression levels of HIF-1α (a,c), GR (b,c) in cells transfected with HIF-1α-siRNA compared to nontransfected cells after
dexamethasone treatment (24h). (d) Quantification of (c) (*P < 0.05 vs siRNA)
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groups. Thus, we conclude that HIF-1α can protect AtT-
20 cells from hypoxia-induced apoptosis. Under normoxic
conditions, dexamethasone (10 nM or 100 nM) increased
mRNA and protein expression levels of HIF-1α, but sup-
pressed HIF-1α expression under hypoxic conditions. GR
expression was upregulated under hypoxic conditions due
to increased HIF-1α mRNA and protein levels. Dexa-
methasone exhibited a stronger suppression of GR expres-
sion in hypoxia than in normoxia. Downregulation of GR
by dexamethasone was greatly improved in cells trans-
fected with HIF-1α siRNA under hypoxic conditions, im-
plying that dexamethasone-mediated suppression of GR
may be HIF-1α dependent.
Whether hypoxia induces a pro- or antiapoptotic re-
sponse remains unclear [15]. There are published studies
in support of both viewpoints. Hypoxia has been shown to
indirectly produce a proapoptotic effect by upregulating
the expression of Bcl-2 family members, or by associating
with and/or stabilizing these proteins [16-19]. However,HIF-1α has also been proposed to have a protective role,
limiting hypoxia-induced apoptosis [20-23]. In this regard,
pancreatic cancer cell lines that constitutively express HIF-
1α are more resistant to apoptosis induced by hypoxia com-
pared to similar cell lines that lack constitutive expression of
HIF-1α [24]. Further evidence supporting an antiapoptotic
role for HIF-1α is demonstrated by the finding that a neu-
tralising monoclonal antibody against vascular endothelial
growth factor (VEGF), the major transcriptional target of
HIF-1α, blocks the antiapoptotic effects of hypoxia in
HepG2 cells [25]. Yoshida et al. [26] employed microarray
analysis to study HIF-1α in the nonfunctional human pituit-
ary adenoma cell line, HP-75, and found that HIF-1α down-
regulated caspase-10. This finding is consistent with our
results, showing that hypoxia-induced HIF-1α increased the
growth and proliferation of AtT-20 cells partly due to the
role of HIF-1α as an inhibitor of hypoxia-induced apoptosis.
Cross-talk between glucocorticoid and hypoxia-
dependent signalling cascades has been demonstrated in
several studies. The first evidence of an interaction
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[9], who found that ligand-dependent activation of GR
enhanced hypoxia-dependent gene expression and hypoxia
response element (HRE) activity in HeLa cells. Leonard
et al. [10] revealed that GR is transcriptionally upregulated
by hypoxia in human renal proximal tubular epithelial
cells. Further, hypoxic upregulation of GR was confirmed
at the level of promoter activity, mRNA, and protein
expression, consistent with our results. Wagner et al. [11]
demonstrated a dexamethasone-mediated inhibition of
HIF-1α target gene expression in hypoxic HEPG2 cells.
Furthermore, they showed retention of HIF-1α in the cyto-
plasm, suggesting a block in nuclear import. Gaber et al.
[27] found a clear inhibition of HIF-1α protein expression,
which resulted in reduced HIF-1 target gene expression,
including VEGF. Interestingly, they also found that PHD1
was regulated in a similar manner as VEGF. Del Peso et al.
[28] showed that PHD1 was upregulated by hypoxia in
HeLa cells. Therefore, we conclude that the interaction
between the glucocorticoid- and hypoxia-dependent signal-
ling cascades is significant as well as varied. These data
reflect the complexity and context-specific alterations asso-
ciated with the differential activation of these cascades in
complex tissue microenvironments.
Our study demonstrated that GR expression levels
were upregulated by HIF-1α under hypoxic conditions.
However, treatment with dexamethasone caused these
levels to decrease in a hypoxia-dependent manner. The
results clearly indicate that HIF-1α may play a role in
the downregulation of GR expression by dexamethasone,
which was further confirmed by transfection of HIF-1α
siRNA. However, additional experimental evidence is
needed to determine the underlying mechanism in-
volved. We are now attempting to employ a luciferase
assay, EMSA, and coimmunoprecipitation to clarify the
mechanism, and an ACTH pituitary adenoma animal
model is under construction.
The current study has profound clinical importance
and supports a therapeutic role for HIF-1α in ACTH
pituitary adenoma due to its antiapoptotic effects and
downregulation of GR. Therefore, we suggest that siRNA
targeting HIF-1α may have potential therapeutic value in
treating ACTH pituitary adenoma.Conclusions
Our present data demonstrate an increased cell prolifera-
tion index in AtT-20 cell lines after hypoxia exposure
through the induction of HIF-1α expression, which played
a crucial role in protecting AtT-20 cells from hypoxia-
induced apoptosis. HIF-1α upregulated GR expression at
both mRNA and protein levels. We also found that the
downregulation of GR by dexamethasone in hypoxic
conditions is probably due to the suppression of HIF-1αby dexamethasone, which means that GR downregulation
by dexamethasone is HIF-1α dependent.
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